BioSpace News Archive

Business

Roivant Sciences Provides Corporate Updates in Advance of First Annual Pipeline Day

Myrtle Potter, former President and COO of Genentech, appointed Vant Operating Chair

July 10, 2018
·
4 min read
Drug Development

Tetra Discovery Partners Initiates Phase 2 Trial of BPN14770 in Fragile X Syndrome

Tetra Discovery Partners today announced the initiation of a Phase 2 study of BPN14770 as a potential treatment for Fragile X Syndrome

July 10, 2018
·
4 min read
Drug Development

Aravive Biologics Completes Phase 1 Trial of Novel GAS6-AXL Pathway Inhibitor, AVB-S6-500

Aravive Biologics, Inc. announced that the company has completed both the single ascending dose and repeat dose portions of its Phase 1 study of AVB-S6-500 in healthy volunteers.

July 10, 2018
·
7 min read
BioMidwest

Pursuit Vascular Achieves Milestone with Shipment of 2 Millionth Pair of ClearGuard® HD Caps

Pursuit Vascular, Inc. reached a milestone in June with the shipment of over 2 million pairs of ClearGuard HD caps during the first 6 months of 2018, an important achievement as the company continues to bring its innovative technology to a broader patient base.

July 10, 2018
·
2 min read
Business

Indivior to Announce and Present Half Year 2018 Results on July 25th

Indivior PLC announced that it will release its half year 2018 results on July 25th at 7:00 a.m. London time (2:00 a.m. U.S. EDT).

July 10, 2018
·
2 min read
Deals

Precision Medicine Group Acquires Scientific And Medical Communications Company ETHOS

Expanded Emphasis On Interpreting The Science Of Complex Medical Innovations Bolsters Precision’s Capabilities to Support Commercial And R&D Client Base

July 10, 2018
·
3 min read
Business

4D Molecular Therapeutics and MedImmune Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease

MedImmune and 4D Molecular Therapeutics announced a collaboration to develop and commercialize a gene therapeutic for patients with chronic lung disease, utilizing 4DMT’s novel discovery platform to generate optimized AAV vectors.

July 10, 2018
·
3 min read
Deals

Rite Aid Sends Letter to Shareholders

Urges Shareholders to Support Rite Aid’s Transformation for the Future by Voting FOR the Merger with Albertsons Companies

July 10, 2018
·
17 min read
Business

Jason Fontenot, Ph.D., Joins Immusoft as Chief Scientific Officer

Respected leader brings expertise in immunology and cell therapy

July 10, 2018
·
3 min read
Drug Development

Realm Therapeutics Announces Publication of Pre-Clinical Study Demonstrating Comparable Activity of PR022 and Topical Tofacitinib in the Treatment of Atopic Dermatitis

Realm Therapeutics plc announces the publication of a pre-clinical study demonstrating comparable activity between PR022, Realm’s proprietary topical gel formulation of high concentration hypochlorous acid (HOCl), and tofacitinib, a topical Janus kinase (JAK) inhibitor

July 10, 2018
·
6 min read